BCL2 and neoplasm: The tumor tissue protein was extracted, and Western blotting indicated that DMF treatment resulted in decreased Bcl-2 expression and increased Bax expression in tumor tissues, resulting in a lower Bcl-2/Bax ratio (all p < 0.01).